Search for: "Sanofi-Aventis" Results 41 - 60 of 563
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Aug 2008, 4:38 pm
Novo Nordisk sued Sanofi-Aventis for infringing 7,241,278. [read post]
19 Jun 2007, 9:45 pm
By Donald Zuhn -- Sanofi-Aventis and Bristol-Myers Squibb announced today (June 19, 2007) that the U.S. [read post]
24 Aug 2010, 5:11 am by By DEALBOOK
Talks between the French pharmaceutical giant Sanofi-Aventis and the American biotech company Genzyme have hit a snag as the two sides seek to agree on a threshhold price that would allow Sanofi to proceed with due diligence, The Wall Street Journal reports. [read post]
23 Mar 2011, 2:44 am by By CHRIS V. NICHOLSON
The French pharmaceutical giant Sanofi-Aventis says it will issue $7 billion worth of notes to help finance its acquisition of the American biotechnology firm Genzyme. [read post]
14 Jan 2011, 5:52 am by By CHRIS V. NICHOLSON
Le Figaro reports that Sanofi-Aventis is prepared to bid as much as $76 a share for Genzyme -- a big increase from its original $69 a share offer. [read post]
9 Feb 2011, 10:20 am by By DUFF WILSON
Viehbacher, chief executive of Sanofi-Aventis, cites "good progress" in talks, but says that due diligence is taking time. [read post]
4 Apr 2011, 6:12 am by By CHRIS V. NICHOLSON
Sanofi-Aventis says it has wrapped up its exchange offer for all Genzyme shares, an offer that expired just before midnight on Friday. [read post]
29 Sep 2010, 3:11 am by By DEALBOOK
Sanofi-Aventis is weighing whether to make a sweetened takeover offer for Genzyme as soon as next week, people with knowledge of the matter told Bloomberg News. [read post]
13 Dec 2010, 1:11 am by By CHRIS V. NICHOLSON
Sanofi Aventis says its $69-a-share bid for Genzyme will remain open until Jan. 21, in a move that will keep the proposed deal alive. [read post]
4 Oct 2010, 11:30 am by By STEVEN M. DAVIDOFF
The Deal Professor examines how Sanofi-Aventis could face a long fight with Genzyme over its hostile bid and how it needs to deal with the Genzyme board. [read post]
1 Nov 2007, 8:20 am
FDA cites Sanofi for shoddy study oversight", published online by Reuters October 24, 2007:Sanofi-Aventis spokeswoman Emmy Tsui said the company intends to provide a detailed response to the letter. [read post]
9 Jul 2016, 4:26 am by Berniard Law Firm
Sanofi-Aventis is a major pharmaceutical company based out of France that does business all over the world. [read post]
20 Aug 2010, 4:47 am by Varun Chhonkar
Judge Gregory Sleet of the US District Court for the District of Delaware lately decided in favor of Sanofi-Aventis in Uroxatral patent lawsuit and ruled that Sanofi’s US Patent Number 4,661,491 is valid and infringed by generic alfuzosin versions from Aurobindo Pharma and Torrent Pharma Inc. [read post]
27 Mar 2011, 6:28 pm
Jones Ward PLC attorney Larry Jones filed a lawsuit this week against pharmaceutical giant sanofi-aventis U.S., Inc. [read post]
29 Jan 2008, 3:13 pm
Sanofi-Aventis spokeswoman Julissa Viana repeated earlier comments saying Aventis was not aware of the fraud in Study 3014 until after it was submitted to the FDA. [read post]
14 Jan 2011, 8:21 am by Ronald V. Miller, Jr.
Bristol-Myers co-markets Avalide and another blood pressure medication, Sanofi-Aventis' Avapro, under a longstanding partnership. [read post]
13 Sep 2008, 4:35 am
According to Sanofi-Aventis' July 18 filing with the House clerk's office, the drugmaker's lobbying efforts were directed in part at follow-on biologics legislation. [read post]
9 Jan 2011, 9:09 pm by Patent Docs
USA 1:11-cv-00018; filed January 6, 2011 in the District Court of Delaware • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
4 Nov 2010, 9:59 pm by Patent Docs
By James DeGiulio -- Sanofi and BMS Awarded $442M in Plavix Patent Suit Apotex has been ordered to pay $442.2 million in damages to sanofi-aventis and Bristol-Myers Squibb Co. for infringing their patent covering the blood thinner Plavix. [read post]